US Broker Ratings

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 85% Upside Potential for Healthcare Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) offers an intriguing opportunity for investors in the healthcare sector, primarily due to its potential upside of 85.74% as suggested by current analyst ratings. With..

Evotec SE (EVO): Investor Outlook Reveals 72.98% Potential Upside Amidst Strategic Collaborations

Investors with an eye on the healthcare sector might want to take a closer look at Evotec SE (EVO), a drug discovery and development company that has been making strides..

Celldex Therapeutics, Inc. (CLDX): Investor Outlook Reveals 105% Upside Potential in Biotech Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands out in the biotechnology landscape, capturing investor interest with its innovative approach to developing therapeutic antibodies for severe inflammatory, allergic, autoimmune, and other diseases...

Astrana Health Inc. (ASTH)

⚠️ No article content returned.

..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Growth Potential and Analyst Ratings Highlight a Promising 13.69% Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is gaining attention among investors for its robust growth trajectory and strategic position in the healthcare sector. As a leading provider of home care..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Insights into Its 16.58% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is positioned at an intriguing juncture, offering potential investors a notable 16.58% upside based on current analyst projections. With its headquarters in Rancho Cucamonga, California,..

GRAIL, Inc. (GRAL) Stock Analysis: Healthcare Innovator with 6.85% Potential Upside

GRAIL, Inc. (GRAL), a trailblazer in the healthcare sector, is making significant strides in the diagnostics and research industry with its innovative cancer detection technologies. Headquartered in Menlo Park, California,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Harnessing a 43% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling proposition. As a key player in the medical care facilities industry, the company..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Promising 44% Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a key player in the biotechnology sector, is capturing the attention of investors with its robust pipeline in precision medicine oncology. With a market capitalization..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 37% Upside Potential Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) has captured the attention of investors in the biotechnology sector with its remarkable revenue growth and significant upside potential. The company, headquartered in Morrisville, North Carolina,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring an 18.54% Upside in Healthcare

The Pennant Group, Inc. (NASDAQ: PNTG) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Eagle, Idaho, this company has carved..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 35% Upside Potential in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the biopharmaceutical industry, is making waves with its robust product line targeting central nervous system (CNS) diseases. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unpacking a Potential 110% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is catching the eye of investors, standing at the forefront of the biotechnology sector with a compelling narrative that combines innovative drug development with promising..

Agios Pharmaceuticals (AGIO) Stock Analysis: Evaluating a High-Stakes Play in Biotechnology with a 15.39% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) has carved out a niche in the dynamic biotechnology industry with its innovative focus on cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is known for..

Evolent Health, Inc (EVH) Investor Outlook: Analysts See 175% Upside Potential

Evolent Health, Inc. (NASDAQ: EVH) stands at a crucial juncture as it navigates challenges in the health information services industry. With a market cap of $463.88 million, this Arlington, Virginia-based..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling a 76% Upside Potential Amid Biotech Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with its focused efforts on treating neurodegenerative and lysosomal storage diseases. Headquartered in South San Francisco, California, this biopharmaceutical..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Through a Challenging Market with Innovative Solutions

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of the healthcare sector as a dynamic player in the health information services industry. With a market capitalization of $2.29 billion,..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 21.81% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its strategic focus on developing innovative treatments for cardiorenal conditions driven..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 31% Potential Upside in the Health Information Services Sector

For investors with an eye on the healthcare sector, Omnicell, Inc. (NASDAQ: OMCL) presents a compelling opportunity. Specializing in medication management solutions, Omnicell operates within the dynamic Health Information Services..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Exploring a Potential 204.96% Upside in the Biotech Sector

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is capturing investor attention with an enticing potential upside of 204.96%, as suggested by recent analyst ratings. Positioned within the healthcare sector and specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds